Related Experiment Videos
Serum sickness-like reactions associated with cefprozil therapy
N Lowery1, G L Kearns, R A Young
1Department of Pediatrics, Arkansas Children's Hospital, Little Rock 72202.
The Journal of Pediatrics
|August 1, 1994
Abstract:
Four patients had serum sickness-like reactions during treatment with cefprozil, a new cephalosporin. Two patients had had previous mild reactions associated with cephalosporin therapy. It remains uncertain whether cefprozil-associated serum sickness-like reaction represents a unique or a class-related adverse drug reaction.
Insights
Four patients experienced serum sickness-like reactions to cefprozil, a new cephalosporin antibiotic. Further research is needed to determine if this reaction is unique to cefprozil or a broader cephalosporin class effect.
Area of Science:
- Pharmacology
- Clinical Medicine
- Adverse Drug Reactions
Background:
- Cephalosporins are widely used antibiotics.
- Newer generation cephalosporins require ongoing safety monitoring.
- Serum sickness-like reactions (SSLRs) are a known adverse drug reaction.
Observation:
- Four patients developed SSLRs during cefprozil treatment.
- Two of these patients had prior mild reactions to cephalosporins.
- Cefprozil is a novel cephalosporin antibiotic.
Findings:
- Cefprozil treatment was associated with SSLRs in four patients.
- A history of cephalosporin hypersensitivity may increase risk.
- The specific mechanism of cefprozil-induced SSLR is unclear.
Implications:
- Clinicians should be aware of potential SSLRs with cefprozil.
- Distinguishing cefprozil SSLR as unique or class-related is critical for patient management.
- Further studies are warranted to elucidate the immunologic basis of cefprozil-associated SSLRs.